Jaeger LB[au] - Search Results

Year	Number of Results
2002	1
2004	1
2005	3
2006	2
2007	1
2009	2
2012	1
2022	0

1

Antisense therapeutics and the treatment of CNS disease.

Jaeger LB, Banks WA. Jaeger LB, et al. Front Biosci. 2004 May 1;9:1720-7. doi: 10.2741/1337. Front Biosci. 2004. PMID: 14977581 Review.

2

Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesis.

Jaeger LB, Nath A. Jaeger LB, et al. Dis Model Mech. 2012 May;5(3):313-22. doi: 10.1242/dmm.008763. Epub 2012 Mar 22. Dis Model Mech. 2012. PMID: 22563057 Free PMC article. Review.

3

Transport of antisense across the blood-brain barrier.

Jaeger LB, Banks WA. Jaeger LB, et al. Methods Mol Med. 2005;106:237-51. doi: 10.1385/1-59259-854-4:237. Methods Mol Med. 2005. PMID: 15375320 Review. No abstract available.

4

Effects of orexin-A on memory processing.

Jaeger LB, Farr SA, Banks WA, Morley JE. Jaeger LB, et al. Peptides. 2002 Sep;23(9):1683-8. doi: 10.1016/s0196-9781(02)00110-9. Peptides. 2002. PMID: 12217429

5

Ghrelin controls hippocampal spine synapse density and memory performance.

Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks WA, Morley JE, Pinto S, Sherwin RS, Xu L, Yamada KA, Sleeman MW, Tschöp MH, Horvath TL. Diano S, et al. Among authors: jaeger lb. Nat Neurosci. 2006 Mar;9(3):381-8. doi: 10.1038/nn1656. Epub 2006 Feb 19. Nat Neurosci. 2006. PMID: 16491079

6

Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition.

Jaeger LB, Dohgu S, Hwang MC, Farr SA, Murphy MP, Fleegal-DeMotta MA, Lynch JL, Robinson SM, Niehoff ML, Johnson SN, Kumar VB, Banks WA. Jaeger LB, et al. J Alzheimers Dis. 2009;17(3):553-70. doi: 10.3233/JAD-2009-1074. J Alzheimers Dis. 2009. PMID: 19433890 Free PMC article.

7

Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease.

Jaeger LB, Dohgu S, Sultana R, Lynch JL, Owen JB, Erickson MA, Shah GN, Price TO, Fleegal-Demotta MA, Butterfield DA, Banks WA. Jaeger LB, et al. Brain Behav Immun. 2009 May;23(4):507-17. doi: 10.1016/j.bbi.2009.01.017. Epub 2009 Feb 6. Brain Behav Immun. 2009. PMID: 19486646 Free PMC article.

8

Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.

Jaeger LB, Banks WA, Varga JL, Schally AV. Jaeger LB, et al. Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12495-500. doi: 10.1073/pnas.0504163102. Epub 2005 Aug 23. Proc Natl Acad Sci U S A. 2005. PMID: 16118272 Free PMC article.

9

Endothelial-specific knockdown of interleukin-1 (IL-1) type 1 receptor differentially alters CNS responses to IL-1 depending on its route of administration.

Ching S, Zhang H, Belevych N, He L, Lai W, Pu XA, Jaeger LB, Chen Q, Quan N. Ching S, et al. Among authors: jaeger lb. J Neurosci. 2007 Sep 26;27(39):10476-86. doi: 10.1523/JNEUROSCI.3357-07.2007. J Neurosci. 2007. PMID: 17898219 Free PMC article.

10

Preproenkephalin targeted antisenses cross the blood-brain barrier to reduce brain methionine enkephalin levels and increase voluntary ethanol drinking.

Banks WA, Jaeger LB, Urayama A, Kumar VB, Hileman SM, Gaskin FS, Llanza NV, Farr SA, Morley JE. Banks WA, et al. Among authors: jaeger lb. Peptides. 2006 Apr;27(4):784-96. doi: 10.1016/j.peptides.2005.09.001. Epub 2005 Oct 17. Peptides. 2006. PMID: 16229925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results